Cambridge Investment Research Advisors, Inc. Corcept Therapeutics Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 26,855 shares of CORT stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,855
Previous 286,250
90.62%
Holding current value
$1.38 Million
Previous $9.3 Million
86.63%
% of portfolio
0.0%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$850 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$514 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$425 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$335 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$196 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...